Autres langues SI-BONE, Inc.

Actions

SIBN

US8257041090

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/05/2024			Varia. 5j.	Varia. 1 janv.
13,55 ^USD	+1,04 %		-9,18 %	-35,45 %

14/05	Transcript : SI-BONE, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
07/05	SI-BONE, INC. : Morgan Stanley favorable sur le dossier	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures	07/05
SI BONE : May 2024 Investor Presentation	06/05
Si-Bone: Q1 Earnings Snapshot	06/05
Earnings Flash (SIBN) SI-BONE Posts Q1 Revenue $37.9M, vs. Street Est of $36.5M	06/05
SI-BONE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024	06/05
Si-Bone, Inc. Increases Revenue Guidance for 2024	06/05
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024	29/04
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024	15/04
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024	04/03
Si-Bone: Q4 Earnings Snapshot	26/02
Earnings Flash (SIBN) SI-BONE Posts Q4 Revenue $38.9M, vs. Street Est of $38.6M	26/02
SI-BONE, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	26/02
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance	26/02
SI-BONE, Inc. Provides Earnings Guidance for the Year 2024	26/02
Si-bone Insider Sold Shares Worth $808,591, According to a Recent SEC Filing	21/02
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024	05/02
SI-Bone Implant Receives Expanded FDA Approval	30/01
SI-Bone Shares Up After Receiving FDA Approval for Expanded Device Use	30/01
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application	30/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SI-BONE, Inc.

Actions

SIBN

US8257041090

Autres langues

Filtres